Refine by
Clinical Trial Articles & Analysis: Older
285 articles found
By modeling and simulating these interactions, scientists can predict the behavior of a drug across various populations and dosing scenarios. This aids in designing clinical trials, personalizing medicine, and improving drug safety profiles. ...
Reduced Late-Stage Failures: With earlier and better detection of potential proarrhythmic risks, developers can mitigate the likelihood of late-stage clinical trial failures, saving both time and resources. Regulatory Support: Global regulatory agencies are increasingly recognizing the value of CiPA’s approach. ...
In 2024, we can expect to see clinical trials that leverage this technology, aiming for a more efficient and rapid response to viral outbreaks. ...
The development of miRNA-based therapies has garnered significant interest, with some products currently in clinical trials. Beyond oncology, miRNA mimics have potential applications in treating various conditions, including cardiovascular diseases, metabolic disorders, and neurodegenerative diseases. By targeting specific pathways involved in disease ...
Furthermore, it has led to accelerated timelines for preclinical and clinical trials, ultimately benefiting patients awaiting lifesaving therapies. ...
Additionally, several cytokines are undergoing clinical trials, including interleukins like IL-1, IL-3, IL-4, IL-6, and IL-11, as well as transforming growth factor beta (TGF-β) and macrophage colony-stimulating factor (M-CSF). ...
Current Research and Future Prospects Research into Wharton’s jelly and its cellular components is rapidly advancing. Clinical trials are underway to better understand their efficacy in treating various conditions. ...
The prime concern resides in assessing the clinical efficacy of these therapies, as their long-term impact is yet to be conclusively quantified. Hence, an extensive lattice of regulations envelops these modalities, mandating rigorous preclinical studies and clinical trials before their eventual public deployment. Furthermore, the cost ...
Clinical trials are the backbone of modern medicine, responsible for bringing innovative, safe, and efficient treatments to market after rigorous testing and evaluation. However, the conventional process of conducting these trials has often been long, expensive, and fraught with inefficiencies¹. The advent of predictive analytics is ...
Medical advancement relies on clinical trials, which are essential for the development of safe and effective innovative treatments. ...
This not only expedites the development of novel therapeutics but also improves the success rate of clinical trials, ultimately benefiting patients in need of innovative treatments. ...
These tests can help determine effective doses and potential side effects, thereby guiding the design of clinical trials.4. Pharmacokinetics and Pharmacodynamics (PK/PD) AnalysisStudying the absorption, distribution, metabolism, and excretion characteristics of ADC in the body, as well as the relationship between drug concentration and efficacy, is the basis for ...
Provenge, a therapeutic vaccine for metastatic prostate cancer that has demonstrated a survival benefit in clinical trials, is approved for treating metastatic prostate cancer. The field of cancer vaccines is fleetly evolving. ...
At the same time, antibody sequencing can also help us evaluate the therapeutic effect and mechanism of antibodies, providing strong support for clinical trials and marketing applications of drugs. Sequencing technology plays a crucial role in the design of antibody drugs and is a compass guiding the development of customized antibody drugs. ...
We recently spoke with Manuela Badiali, Rita Congiu, and Stefania Murru from the Laboratory of Genetics and Genomics, Microcitemico Pediatric Hospital – A. Cao, Cagliari, about how SOPHiA DDM™ RNAtarget Technology has helped them optimize their variant analysis workflow. ...
Dr. Kate Sasser from Tempus led a discussion on the potential of antibody-drug conjugates (ADCs), their challenges in targeting tumor antigens, and the future of cancer treatment with Dr. Daniel Johnson, Dr. Funda Meric-Bernstam, and Dr. Kellogg Parsons. The oncology field is rapidly advancing with the development of antibody-drug conjugates (ADCs), offering new hope for ...
ByTempus
Only 10% of drugs advanced to the clinical stage are successfully brought to market, with half of all failures attributed to lack of clinical efficacy. ...
Understanding Sleep Apnea and Its Types Sleep apnea is a sleep-related breathing disorder that results in poor sleep quality and can lead to daytime fatigue or sleepiness, forgetfulness, and irritability. According to the Mayo Clinic, there are 3 types of sleep apnea to be aware of as follows: OSA or obstructive sleep apnea is the more common form of the disorder and affects roughly 30% of ...
While mRNA vaccines have shown remarkable efficacy in clinical trials and real-world use, researchers are constantly looking for ways to enhance their effectiveness and duration of protection. ...
This not only expedites the development of novel therapeutics but also improves the success rate of clinical trials, ultimately benefiting patients in need of innovative treatments. ...